Related Experiment Video
Updated: Aug 11, 2026
08:23
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
Published on: April 12, 2016
Neurologic involvement of systemic cancer
Critical Care Nursing Clinics of North America
|March 1, 1995
Summary
Recognizing neurologic complications in cancer patients is crucial for prompt treatment and better outcomes. Nurses play a vital role in identifying these emergencies, which can arise from cancer itself or its treatments.
Area of Science:
- Oncology
- Neurology
- Critical Care Nursing
Background:
- Neurologic complications are frequent in patients with systemic cancer.
- These complications can stem from the cancer itself or its treatments, leading to neurotoxicities.
- Such conditions often manifest as neurologic emergencies requiring immediate attention.
Purpose of the Study:
- To emphasize the importance of early recognition of neurologic complications in cancer patients.
- To highlight the critical role of nurses in managing these emergent conditions.
- To underscore the impact of timely diagnosis and intervention on patient outcomes.
Main Methods:
- This abstract focuses on the clinical presentation and nursing implications of neurologic complications in cancer.
- It reviews the common causes and manifestations of these neurologic issues.
- The text stresses the need for nurses to be vigilant in monitoring and assessing cancer patients for neurologic changes.
Main Results:
- Neurologic complications are a significant concern in systemic cancer care.
- Early identification and management are key to improving patient prognosis.
- Nurses are essential in the early detection and response to these critical events.
Conclusions:
- Nurses in critical care settings must be adept at recognizing the signs and symptoms of neurologic complications in cancer patients.
- Prompt recognition and intervention are imperative for optimizing patient outcomes.
- Understanding these complications is vital for effective cancer patient management.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...